A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer.
Wakelee
Heather
H
Stanford Clinical Cancer Center, Stanford, CA 94305-5826, USA. hwakelee@Stanford.edu
Fisher
George A
GA
D000328:Adult; D004999:Amifostine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D019610:Cytoprotection; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077146:Irinotecan; D009362:Neoplasm Metastasis
D000077146:Irinotecan; D004999:Amifostine; D002166:Camptothecin